Guillem Garcia-Llorens

Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey

J. Castell, G. Quintás, Erika Moro, 2021, Scientific Reports.

Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection

C. Ribes-Koninckx, J. Castell, R. Bort, 2022, Scientific Reports.

A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes.

C. Verfaillie, J. Castell, G. Quintás, 2022, Journal of proteome research.

A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies

J. Castell, R. Bort, E. Pareja, 2023, Stem Cell Research & Therapy.

Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate “Diseased” Hepatocytes for Accurate Diagnosis

J. Castell, T. Jaijo, R. Bort, 2022, Journal of personalized medicine.

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways

J. Pérez-Rojas, Guillem Garcia-Llorens, Iván Rienda, 2024, International journal of molecular sciences.